Literature DB >> 18054940

Association of ischemia-modified albumin and melatonin in patients with ST-elevation myocardial infarction.

Alberto Dominguez-Rodriguez1, Pedro Abreu-Gonzalez, Martín J Garcia-Gonzalez, Sima Samimi-Fard, Russel J Reiter, Juan Carlos Kaski.   

Abstract

INTRODUCTION: It has been proposed that reactive oxygen species (ROS) generated during myocardial ischemia-reperfusion modify the N-terminus of serum albumin resulting in ischemia-modified albumin (IMA) formation. Likewise, several recent publications provide evidence that melatonin, a circadian endogenously produced indolamine, is a direct scavenger of ROS. We sought to investigate the relationship between IMA and melatonin in ST- elevation myocardial infarction (STEMI).
METHODS: We compared IMA and melatonin levels in 27 patients with STEMI undergoing primary angioplasty and 20 age- and gender-matched healthy normal subjects. Blood samples were drawn at 02:00h (night period) and 09:00h (day period) while patients were resting, to assess IMA and melatonin.
RESULTS: In both groups, melatonin concentrations maintained a diurnal variation, but the difference between nocturnal and diurnal levels was less in the STEMI-patients than in the control group (p<0.001). In contrast to findings about melatonin, IMA levels showed no diurnal variations in control subjects. However, the STEMI group showed a diurnal fluctuation with significantly higher levels at 02:00h (p<0.01). The association between IMA and melatonin remained statistically significant after adjustment for cardiovascular risk factors. An inverse correlation between IMA and melatonin at 02:00h and at 09:00h was observed, with respective r-values of -0.42 (p<0.03) and -0.57 (p<0.002).
CONCLUSIONS: Circulating IMA is negatively correlated to melatonin in STEMI-patients. Our results suggest that melatonin might exert a beneficial effect as a radical scavenger in a human model of myocardial ischemia-reperfusion.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18054940     DOI: 10.1016/j.atherosclerosis.2007.10.019

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  11 in total

1.  Myocardial ischemia-reperfusion injury: Possible role of melatonin.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez
Journal:  World J Cardiol       Date:  2010-08-26

Review 2.  Diagnostic Accuracy of Ischemia-Modified Albumin for Acute Coronary Syndrome: A Systematic Review and Meta-Analysis.

Authors:  Hyungoo Shin; Jae-Guk Kim; Bo-Hyoung Jang; Tae-Ho Lim; Wonhee Kim; Youngsuk Cho; Kyu-Sun Choi; Min-Kyun Na; Chiwon Ahn; Juncheol Lee
Journal:  Medicina (Kaunas)       Date:  2022-04-28       Impact factor: 2.948

3.  Diurnal variation of melatonin and cortisol is maintained in non-septic intensive care patients.

Authors:  Asko Riutta; Pauli Ylitalo; Seppo Kaukinen
Journal:  Intensive Care Med       Date:  2009-07-04       Impact factor: 17.440

4.  The clinical assessment of ischaemia modified albumin and troponin I in the early diagnosis of the acute coronary syndrome.

Authors:  Sangita M Patil; M P Banker; Ramchandra K Padalkar; Abhijit P Pathak; Sonali S Bhagat; Rahul A Ghone; Anjali S Phatake
Journal:  J Clin Diagn Res       Date:  2013-05-01

Review 5.  Cardioprotection and pharmacological therapies in acute myocardial infarction: Challenges in the current era.

Authors:  Alberto Dominguez-Rodriguez; Pedro Abreu-Gonzalez; Russel J Reiter
Journal:  World J Cardiol       Date:  2014-03-26

6.  Melatonin and Cardioprotection in Humans: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Authors:  Alberto Domínguez-Rodríguez; Pedro Abreu-González; Néstor Báez-Ferrer; Russel J Reiter; Pablo Avanzas; Daniel Hernández-Vaquero
Journal:  Front Cardiovasc Med       Date:  2021-05-12

7.  Ischaemia modified albumin: Does it bolster our diagnostic ammunition?

Authors:  Dilip Gude; Ramesh Babu Byrapaneni
Journal:  Indian J Anaesth       Date:  2011-07

8.  Ischemia modified albumin (IMA) in acute coronary syndrome (ACS) and left bundle branch block (LBBB). Does it make the difference?

Authors:  Mohamed Abdel Kader Abdel Wahab
Journal:  Egypt Heart J       Date:  2017-02-20

Review 9.  Novel Combined Antioxidant Strategy against Hypertension, Acute Myocardial Infarction and Postoperative Atrial Fibrillation.

Authors:  Ramón Rodrigo; Jaime González-Montero; Camilo G Sotomayor
Journal:  Biomedicines       Date:  2021-05-30

10.  Effect of Melatonin on Cardiac Injury after Primary Percutaneous Coronary Intervention: a Randomized Controlled Trial.

Authors:  Padideh Ghaeli; Shaghayegh Vejdani; Atefeh Ariamanesh; Azita Hajhossein Talasaz
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.